Related Experiment Video
Updated: Jun 13, 2026

04:38
Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
Published on: April 19, 2024
Uniportal Robotic-Assisted Versus Video-Assisted Thoracoscopic Surgery for Anatomical Lung Resection in Non-Small
Mehlika İşcan1, Ömer Yavuz1, Reyhan Ertan1
1Department of Thoracic Surgery, Başakşehir Çam ve Sakura City Hospital, 34480 Istanbul, Türkiye.
Journal of Clinical Medicine
|June 12, 2026
Summary
Uniportal robotic-assisted (uRATS) lung cancer surgery showed similar oncologic outcomes to uniportal video-assisted (uVATS) surgery. However, uRATS demonstrated faster recovery with less pain and shorter hospital stays, suggesting potential benefits for patients.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Direct comparisons of uniportal robotic-assisted surgery (uRATS) and uniportal video-assisted surgery (uVATS) for non-small cell lung cancer (NSCLC) are limited.
- This study addresses the scarcity of data by comparing oncologic radicality and perioperative outcomes between these two uniportal approaches.
Purpose of the Study:
- To compare the oncologic radicality and perioperative outcomes of uniportal robotic-assisted thoracoscopic surgery (uRATS) versus uniportal video-assisted thoracoscopic surgery (uVATS) for non-small cell lung cancer (NSCLC).
Main Methods:
- A retrospective cohort study of 56 consecutive NSCLC patients undergoing uniportal anatomical resection (12 uRATS, 44 uVATS).
- Primary endpoint: oncologic radicality (lymph node dissection quality).
- Secondary endpoints: operative time, blood loss, pain, recovery metrics, and textbook outcome.
Main Results:
- All patients achieved complete (R0) resection.
- uRATS group showed significantly more lymph nodes dissected (13 vs. 7; p=0.049) and a trend towards more mediastinal stations sampled (4 vs. 3; p=0.061).
- uRATS was associated with longer operative time (220 vs. 135 min; p<0.001) but favored uRATS for reduced air-leak duration (0 vs. 2 days; p<0.001), shorter hospital stay (2 vs. 3 days; p=0.022), and less discharge pain (p=0.017).
Conclusions:
- In a uniportal-experienced center, uRATS demonstrated comparable intraoperative oncologic quality to uVATS for NSCLC.
- Perioperative recovery metrics significantly favored uRATS.
- Larger multicenter studies with extended follow-up are recommended to further validate these findings.

